Cargando…
In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML
Different fusion oncogenes in acute myeloid leukemia (AML) have distinct clinical and laboratory features suggesting different modes of malignant transformation. Here we compare the in vitro effects of representatives of 4 major groups of AML fusion oncogenes on primary human CD34+ cells. As expecte...
Autores principales: | Abdul-Nabi, Anmaar M., Yassin, Enas R., Varghese, Nobish, Deshmukh, Hrishikesh, Yaseen, Nabeel R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929205/ https://www.ncbi.nlm.nih.gov/pubmed/20805992 http://dx.doi.org/10.1371/journal.pone.0012464 |
Ejemplares similares
-
Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: Role of a conserved helicase motif
por: Yassin, Enas R., et al.
Publicado: (2010) -
Dissection of the Transformation of Primary Human Hematopoietic Cells by the Oncogene NUP98-HOXA9
por: Yassin, Enas R., et al.
Publicado: (2009) -
Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
por: Mu, Guangfu, et al.
Publicado: (2020) -
ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML
por: Capala, Marta E., et al.
Publicado: (2014) -
ENL links histone acetylation to oncogenic gene expression in AML
por: Wan, Liling, et al.
Publicado: (2017)